Determination of Platelet Count and platelet Indices in Women after Normal Delivery in Shendi Town, Sudan

Background: Delivery is the process of birth. As the uterus contracts, the lower part stretches and thins, the cervix expands, the birth canal is formed, and the baby sinks through the pelvis, Platelet counts of less than 150,000 per cubic millimeter during uncomplicated pregnancies are described as gestational thrombocytopenia if no alternative cause is identified. Platelet counts may be even lower in women with pregnancy-related complications. Objective: The purpose of this study was to measure the platelet count and platelet index in women after normal delivery. Methods: This descriptive study was conducted in the city of Shendi during the period from March (2021) to January (2022) and measured the platelet count and platelet index in women after normal delivery. P.value of the test at the 95-confidence level was 0.000, less than 0.05, indicating significant variation between the case and control groups in platelet counts. Hundreds of venous blood samples were collected for use in this study, 50 of which were collected from the test group and 50 from the control group. Platelet counts and platelet indices (including platelet critical value (PCT), platelet distribution width (PDW), and mean platelet volume (MPV) were determined for all samples and performed in an automated manner using a hematology analyzer. Results: The study showed that the mean platelet count in the delivery group was 147.84 compared to 263.14 in the control group. The P. value was significant (P. value 0.000). The most affected age for platelet count in the study group was 30 years and older, with a platelet count percentage of 84%. The most effective number of workers for platelet counts in postpartum women was 2 or more workers. The platelet count percentage was 84%. The study showed that the mean platelet volume (MPV) for the delivery group was 8.696 compared to 8.616 for the control group. The value of the test was not significant (0.620). The mean platelet distribution width (PDW) was 15.750 for the treatment group and 15.828 for the control group. The P. value was not significant (0.418).